These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 32011440

  • 1. Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report.
    Watanabe T, Takizawa N, Nagasaka T, Nakamura Y, Ikai H, Yamamoto M, Murai Y, Takasugi K, Yokoyama-Kokuryo W, Fujita Y.
    Medicine (Baltimore); 2020 Jan; 99(3):e18600. PubMed ID: 32011440
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.
    Endo Y, Koga T, Suzuki T, Hara K, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Kawakami A.
    Medicine (Baltimore); 2018 Apr; 97(15):e0436. PubMed ID: 29642214
    [Abstract] [Full Text] [Related]

  • 3. Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.
    Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Hosono Y, Mimori T, Kawakami A.
    Medicine (Baltimore); 2018 Jun; 97(26):e11024. PubMed ID: 29952940
    [Abstract] [Full Text] [Related]

  • 4. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM.
    Koga T, Fujikawa K, Horai Y, Okada A, Kawashiri SY, Iwamoto N, Suzuki T, Nakashima Y, Tamai M, Arima K, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Ishimatsu Y, Mukae H, Kuwana M, Kohno S, Eguchi K, Aoyagi K, Kawakami A.
    Rheumatology (Oxford); 2012 Jul; 51(7):1278-84. PubMed ID: 22378718
    [Abstract] [Full Text] [Related]

  • 5. Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
    Matsuda KM, Yoshizaki A, Kuzumi A, Fukasawa T, Ebata S, Yoshizaki-Ogawa A, Sato S.
    J Dermatol; 2020 May; 47(5):483-489. PubMed ID: 32096271
    [Abstract] [Full Text] [Related]

  • 6. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
    Yashiro M, Asano T, Sato S, Kobayashi H, Watanabe H, Miyata M, Migita K.
    Fukushima J Med Sci; 2018 May; 64(2):89-94. PubMed ID: 30158335
    [Abstract] [Full Text] [Related]

  • 7. Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report.
    Ishikawa Y, Kasuya T, Fujiwara M, Kita Y.
    Medicine (Baltimore); 2020 Sep 11; 99(37):e21943. PubMed ID: 32925726
    [Abstract] [Full Text] [Related]

  • 8. Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.
    Wu W, Guo L, Fu Y, Wang K, Zhang D, Xu W, Chen Z, Ye S.
    Clin Rev Allergy Immunol; 2021 Apr 11; 60(2):293-304. PubMed ID: 33405101
    [Abstract] [Full Text] [Related]

  • 9. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M.
    Respir Med; 2018 Jul 11; 140():1-5. PubMed ID: 29957268
    [Abstract] [Full Text] [Related]

  • 10. Management of anti-melanoma differentiation-associated gene 5 antibody-induced refractory dermatomyositis complicated by interstitial pneumonia using tofacitinib and its outcomes: a case report.
    Imai Y, Yorozuya T, Hatakeyama T, Nishimaki T, Takahashi T, Ishikawa T, Kondoh S, Asai Y, Mori Y, Saito A, Nishikiori H, Hosaka M, Chiba H.
    J Med Case Rep; 2024 Sep 28; 18(1):471. PubMed ID: 39334485
    [Abstract] [Full Text] [Related]

  • 11. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
    Hou J, Zhou ZX, Li JG, Xu YJ, Ding YC.
    Zhonghua Er Ke Za Zhi; 2019 Dec 02; 57(12):928-933. PubMed ID: 31795559
    [Abstract] [Full Text] [Related]

  • 12. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease.
    Matsushita T, Kobayashi T, Kano M, Hamaguchi Y, Takehara K.
    J Dermatol; 2019 Dec 02; 46(12):1190-1196. PubMed ID: 31631384
    [Abstract] [Full Text] [Related]

  • 13. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
    Sakamoto S, Okamoto M, Kaieda S, Fujimoto K, Nagata S, Tominaga M, Nakamura M, Zaizen Y, Nouno T, Koga T, Kawayama T, Kuwana M, Ida H, Hoshino T.
    Respir Investig; 2018 Nov 02; 56(6):464-472. PubMed ID: 30150008
    [Abstract] [Full Text] [Related]

  • 14. Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to Tofacitinib.
    Yamazoe M, Takeda K, Nagano Y, Nagano K, Kato K, Inoue T, Horiuchi K, Kamada K.
    Intern Med; 2024 Sep 15; 63(18):2571-2578. PubMed ID: 38346740
    [Abstract] [Full Text] [Related]

  • 15. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
    Quintana-Ortega C, Remesal A, Ruiz de Valbuena M, de la Serna O, Laplaza-González M, Álvarez-Rojas E, Udaondo C, Alcobendas R, Murias S.
    Mod Rheumatol Case Rep; 2021 Jan 15; 5(1):101-107. PubMed ID: 33019894
    [Abstract] [Full Text] [Related]

  • 16. Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis.
    Horai Y, Koga T, Fujikawa K, Takatani A, Nishino A, Nakashima Y, Suzuki T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Ida H, Kakugawa T, Sakamoto N, Ishimatsu Y, Mukae H, Hamaguchi Y, Fujimoto M, Kuwana M, Origuchi T, Kohno S, Kawakami A.
    Mod Rheumatol; 2015 Jan 15; 25(1):85-9. PubMed ID: 24716595
    [Abstract] [Full Text] [Related]

  • 17. Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody.
    Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T.
    J Autoimmun; 2017 Feb 15; 77():116-122. PubMed ID: 27919567
    [Abstract] [Full Text] [Related]

  • 18. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R.
    J Rheumatol; 2017 Mar 15; 44(3):319-325. PubMed ID: 28089977
    [Abstract] [Full Text] [Related]

  • 19. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
    J Rheumatol; 2019 Aug 15; 46(8):935-942. PubMed ID: 31092718
    [Abstract] [Full Text] [Related]

  • 20. Associations between anti-melanoma differentiation-associated gene 5 antibody and demographics, clinical characteristics and laboratory results of patients with dermatomyositis: A systematic meta-analysis.
    Li J, Liu Y, Li Y, Li F, Wang K, Pan W, Meng D.
    J Dermatol; 2018 Jan 15; 45(1):46-52. PubMed ID: 28983955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.